EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

The Current State of Biotransformation Science – Industry Survey of In Vitro and In Vivo Practices, Clinical Translation, and Future Trends

John P Savaryn, Kevin Coe, Matthew A Cerny, Kevin Colizza, Patricia Moliner, Lloyd King, Bin Ma, Jim Atherton, Adam Auclair, Mark T Cancilla, Marsha Eno, Ulrik Jurva und 15 weitere

Pharmaceutical Research · 2024-11 · 41 (11) · 2079-2093

DOI: 10.1007/s11095-024-03787-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Research, online erschienen am 04.11.2024. Verfasst von John P Savaryn und 26 weiteren Autor:innen. Beteiligte Einrichtung: AbbVie, Quantitative, Translational & ADME Sciences, North Chicago, IL, USA. john.savaryn@abbvie.com. Hauptthemen laut MEDLINE: Biotransformation, Drug Industry. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Embedded within the field of drug metabolism and pharmacokinetics (DMPK), biotransformation is a discipline that studies the origins, disposition, and structural identity of metabolites to provide a comprehensive safety assessment, including the assessment of exposure coverage in toxicological species. Spanning discovery and development, metabolite identification (metID) scientists employ various strategies and tools to address stage-specific questions aimed at guiding the maturation of early chemical matter into drug candidates. During this process, the identity of major (and minor) circulating human metabolites is ascertained to comply with the regulatory requirements such as the Metabolites in Safety Testing (MIST) guidance. Through the International Consortium for Innovation and Quality in Pharmaceutical Development (IQ), the "Translatability of MetID In Vitro Systems Working Group" was created within the Translational and ADME Sciences Leadership Group. The remit of this group was to objectively determine how accurate commonly employed in vitro systems have been with respect to prediction of circulating human metabolites, both qualitatively and quantitatively. A survey composed of 34 questions was conducted across 26 pharmaceutical companies to obtain a foundational understanding of current metID practices, preclinically and clinically, as well as to provide perspective on how successful these practices have been at predicting circulating human metabolites. The results of this survey are presented as an initial snapshot of current industry-based metID practices, including our perspective on how a harmonized framework for the conduct of in vitro metID studies could be established. Future perspectives from current practices to emerging advances with greater translational capability are also provided.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiotransformationDrug IndustryHumansAnimalsPharmaceutical PreparationsSurveys and QuestionnairesDrug DevelopmentTranslational Research, BiomedicalDrug DiscoveryDrug Evaluation, Preclinical

Stichwörter der Autor:innen

ADMEIVIVCMetIDbiotransformation

Substanzen

Pharmaceutical Preparations

Autor:innen und Institutionen

  • AbbVie, Quantitative, Translational & ADME Sciences, North Chicago, IL, USA. john.savaryn@abbvie.com.
  • J&J, Translational PKPD & Investigational Toxicology, San Diego, CA, USA.
  • Pfizer, Inc, Groton, CT, USA.
  • GSK, DMPK Disposition and Biotransformation, Collegeville, PA, USA. kevin.x.colizza@gsk.com.
  • Sanofi, Montpellier, France.
  • UCB Biopharma, Dept. of DMPK, Slough, UK.

Zitieren

APA

Savaryn, J. P., Coe, K., Cerny, M. A., Colizza, K., Moliner, P., King, L., Ma, B., Atherton, J., Auclair, A., Cancilla, M. T., Eno, M., Jurva, U., Yue, Q., Zhu, S. X., Freiberger, E., Zhong, G., Barlock, B., Nachtigall, J., Laboureur, L., …, & Jenkins, G. J. (2024). The Current State of Biotransformation Science – Industry Survey of In Vitro and In Vivo Practices, Clinical Translation, and Future Trends. Pharmaceutical Research, 41(11), 2079-2093. https://doi.org/10.1007/s11095-024-03787-y

Vancouver

Savaryn JP, Coe K, Cerny MA, Colizza K, Moliner P, King L, et al. The Current State of Biotransformation Science – Industry Survey of In Vitro and In Vivo Practices, Clinical Translation, and Future Trends. Pharmaceutical Research. 2024;41(11):2079-2093. doi:10.1007/s11095-024-03787-y

BibTeX
@article{Savaryn2024,
  author = {Savaryn, John P and Coe, Kevin and Cerny, Matthew A and Colizza, Kevin and Moliner, Patricia and King, Lloyd and Ma, Bin and Atherton, Jim and Auclair, Adam and Cancilla, Mark T and Eno, Marsha and Jurva, Ulrik and Yue, Qin and Zhu, Sean Xiaochun and Freiberger, Elyse and Zhong, Guo and Barlock, Ben and Nachtigall, Jonny and Laboureur, Laurent and Pusalkar, Sandeepraj and Guo, Runcong and Niehues, Michael and Hauri, Simon and Carreras, Ester Tor and Maurer, Christine and Prakash, Chandra and Jenkins, Gary J},
  title = {The Current State of Biotransformation Science – Industry Survey of In Vitro and In Vivo Practices, Clinical Translation, and Future Trends},
  journal = {Pharmaceutical Research},
  year = {2024},
  volume = {41},
  number = {11},
  pages = {2079--2093},
  doi = {10.1007/s11095-024-03787-y}
}
Kostenlos starten →